Influence
July 1, 2025

Shortening the Patient Health Questionnaire–9—When Brief Scales May Suffice

Kurt Kroenke, MD

Published in JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Kurt Kroenke, MD

A new depression screening tool, the Quick PHQ-3 (QP-3), has been developed as a streamlined version of the widely used 9-item Patient Health Questionnaire (PHQ-9). The QP-3 includes just three items—interest, depressed mood and self-esteem—and demonstrated 98% sensitivity and 76% specificity in identifying moderate or greater depression symptoms.

The tool was evaluated using data from over 96,000 respondents across all 50 U.S. states. The study employed advanced psychometric techniques and was conducted in four waves to ensure reliability across a demographically diverse population. The QP-3’s performance was found to be comparable to longer instruments such as the 4-item PHQ-Dep-4.

Although the QP-3 has not yet been validated against structured psychiatric interviews, its utility is promising in scenarios where brief assessments are necessary. These include mobile health applications, large-scale health screenings or research settings where depression is a secondary outcome.

The full PHQ-9 remains the preferred tool when comprehensive evaluation is required. It captures the full range of diagnostic criteria for major depressive disorder, tracks residual symptoms, includes a critical item on suicidal ideation and supports treatment decisions based on established severity cutoffs.

Additionally, a “gated” approach—using a single-item screener followed by the remaining items only when necessary—has shown potential to cut response burden by nearly half without compromising accuracy.

The availability of brief validated screeners like the QP-3 enhances options for mental health assessment across diverse settings and populations.

Authors:

Kurt Kroenke1,2

Affiliations

1Division of General Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis

2Regenstrief Institute Inc, Indianapolis, Indiana

Partners

Related News

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time

Arthur H. Owora, PhD

Predictive correlates of poor sleep associated with increased risk of severe asthma exacerbations among children with moderate-to-severe asthma

Published in Pediatric Allergy and Immunology. Here is a link to the article. Regenstrief Institute author: Arthur H. Owora,

Atlanta City Skyline

Regenstrief Institute experts will lead presentations, participate in panels at the AMIA 2025

Regenstrief Institute informaticians and other data experts will share their research insights and innovations from November 15-19 during the